Citations

Clear

6273 citation(s) found for "To, Andrew".

Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa
Garg, Amit , Strunk, Andrew , Midgette, Bria, Frasier, Kelly , Cohn, Erica, Aarts, Pim , Alhusayen, Raed , Bechara, Bitte Falk G., Brassard, Alain, Brown, Debra, Emtestam, Lennart , Benhadou, Farida , Fernández‐Peñas, Pablo , Gebauer, Kurt , Horváth, Barbara , Marzano, Angelo Valerio , Orenstein, Lauren A.V. , Pascual, J.C. , Piguet, Vincent, Resnik, Barry I., Roth, Gretchen M. , Straalen, Kelsey van, Ingram, John R , Ingram, J R , Garg, Amit, Cohn, Erica, Alavi, Afsáneh , Bettoli, Vincenzo , Chandran, Nisha Suyien , Choon, Siew Eng , Cohen, Steven R. , Daveluy, Steven , Mármol, V. del , Dellavalle, Robert Paul , Flowers, Richard Hal , Frew, John W. , Giamarellos‐Bourboulis, Evangelos J. , Goldfarb, Noah , Hsiao, Jennifer L. , Jemec, Gregor B. E. , Lowes, Michelle A , Matusiak, Łukasz , Micheletti, Robert , Oon, Hazel H. , Ortega‐Loayza, Alex G. , Paek, So Yeon , Rosmarin, David M. , Sayed, Christopher J. , Silva, Dimitri Luz Felipe da , Thorlacius, Linnea , Tzellos, Thrasyvoulos , Zee, Hessel H. van der , Straalen, Kelsey R. van , Ingram, John R.

Mayo Clinic

JAMA Dermatology | November 26, 2025 | Volume: 162 | Issue: 1 | Pages: 72

10.1001/jamadermatol.2025.4652 | PMID 41296358 Get It

Importance Accurate classification and reliability in assessment for lesions of hidradenitis suppurativa (HS) by investigators is critical to the determination of responder status and to overall data quality in clinical trials. Objective To establish consensus-based morphological definitions of HS lesions and guidance statements that standardize investigator lesion assessments for implementation in clinical trials. Evidence Review Health professionals (primarily dermatologists) with expertise in the measurement of HS disease activity as well as novice raters completed a preliminary questionnaire in which participants were asked to assess images of HS lesions and provide qualitative feedback on their decision making. Based on this feedback, detailed morphologic definitions for lesions and guidance statements that standardize lesion assessments were formulated and presented for consensus voting in 2 electronic Delphi surveys. A virtual group discussion after round 1 supported participants in round 2 voting. Findings Response rates were 84.7% (50 of 59), 86.0% (43 of 50), and 90.9% (40 of 44) in the preliminary, electronic Delphi round 1, and electronic Delphi round 2 surveys, respectively. Morphological definitions for 11 lesion types achieved the prespecified 70% consensus threshold, with 9 definitions reaching at least 90% agreement. After 2 electronic Delphi rounds, 16 of 18 guidance statements achieved the prespecified consensus threshold, with 13 statements receiving endorsement from more than 80% of participants. Two guidance statements related to assessment of tunneled plaques with multiple openings and assessment of scalp lesions failed to reach consensus. Conclusions and Relevance Common morphologic definitions and guidance that standardize assessment of HS lesions can be implemented in clinical trial protocols and investigator trainings with the goals of improving accuracy and reliability of investigator ratings.
Renal Replacement Therapy in Lupus Nephritis–Related End‐Stage Kidney Disease: A Systematic Review and Meta‐Analysis
Jorge, April , Bartels, Christie M. , Cunha, Joanne S., DeQuattro, Kimberly , Fava, Andrea , Garg, Shivani , Greco, Jessica , Cuéllar‐Gutiérrez, María C. , Iyer, Priyanka , Johannemann, Andrew, Kasturi, S.Psi. Taufik , Khawandi, Jana , Legge, Alexandra , Liang, Kelly V. , Lockwood, Megan M. , Sánchez-Rodríguez, Alain , Turgunbaev, Marat, Williams, Jessica N. , Sammaritano, Lisa R. , Bermas, Bonnie L. , Dall’Era, Maria , Hiraki, Linda T. , Turner, Amy S. , Jorge, April , Bartels, Christie M , DeQuattro, Kimberly , Fava, Andrea , Figueroa-Parra, Gabriel , Garg, Shivani , Cuéllar-Gutiérrez, María C, Kirou, Kyriakos A , Lockwood, Megan M , Sanchez-Rodriguez, Alain , Williams, Jessica N , Sammaritano, Lisa R , Askanase, Anca , Bermas, Bonnie , Duarte-García, Alí , Hiraki, Linda T , Rovin, Brad H , Turner, Amy S , Mustafa, Reem A , Kawtharany, Hassan , Azzam, Muayad , Figueroa‐Parra, Gabriel , Iyer, Priyanka, Kirou, Kyriakos A. , Duarte‐García, Alí , Rovin, Brad H. , Son, Mary Beth F.

Mayo Clinic

ACR Open Rheumatology | November 26, 2025 | Volume: 7 | Issue: 12 | Pages: No page available

10.1002/acr2.70121 | PMID 41294263 Get It

Objective To assess the impact of renal replacement therapy in people with lupus nephritis (LN)–associated end‐stage kidney disease (ESKD) and support the development of the 2024 American College of Rheumatology LN treatment guidelines. Methods We conducted a systematic literature review and meta‐analysis to address three Population, Intervention, Comparison, and Outcome (PICO) questions related to renal replacement therapy for ESKD due to LN, including comparisons of kidney transplant versus dialysis, hemodialysis versus peritoneal dialysis, and preemptive kidney transplant versus no preemptive kidney transplant. Outcomes of interest included mortality, cardiovascular (CV) events, infections, lupus flares, disease‐related damage, graft failure, and quality of life. We conducted a meta‐analysis and analyzed hazard ratios for time‐to‐event analyses and risk ratios for dichotomous outcomes, as well as absolute risk estimates. Results Sixteen comparative observational studies addressed at least one of the three PICO questions. Kidney transplant was found to reduce the risks of all‐cause mortality, CV mortality, infection‐related mortality, and CV events compared with dialysis (high certainty). Dialysis modality (peritoneal vs hemodialysis) was not associated with mortality (high certainty) or with other outcomes of infection, CV complications, and systemic lupus erythematosus flares (low certainty). Preemptive kidney transplant was associated with lower risks of graft failure and mortality (low certainty). Conclusion This systematic review identified improved outcomes with kidney transplant versus dialysis for people with LN‐associated ESKD and potential benefits of preemptive kidney transplant. This evidence supports the use of kidney transplant as a preferred renal replacement therapy for people with LN‐ESKD.
Predicting Nonidiopathic Scoliosis from Plain Radiographs
Mulford, Kellen L. , Nugraha, Hans Kristian , Todderud, Julia E , Pumford, Andrew D. , Milbrandt, Todd A. , Huddleston, P.M. , Helgeson, Melvin D. , Larson, A. Noelle , Nugraha, Hans K , Pumford, Andrew , Huddleston, Paul M , Larson, A Noelle

Mayo Clinic

JBJS Open Access | November 25, 2025 | Volume: 10 | Issue: 4 | Pages: No page available

10.2106/jbjs.oa.25.00257 | PMID 41281371 Get It

Background: Scoliosis has various etiologies, ranging from idiopathic, congenital, to those with spinal cord abnormalities. Advanced imaging is not always feasible and limited by cost, low-yield, and anesthesia risks in children. Given artificial intelligence's potential, we hypothesize that a deep learning (DL)–based image classifier will demonstrate superior performance in radiographic classification of scoliosis etiology compared witht experienced spine surgeons based on spine radiographs. Methods: One thousand thirty-six pediatric patients from single institution with scoliosis diagnosis and paired anterior-posterior - lateral images were included. Patients were manually classified based on their scoliosis etiology from chart review, including previous spine imaging studies when available. Categories included idiopathic, congenital, and spinal cord pathology. Images were randomized and assigned for training, validation, and testing. A DL-classifier using EfficientNet B4 architecture was trained on the radiographs. Accuracy and positive predictive value as defined by precision, recall, and F1-score were calculated to assess final performance metrics. Results: The trained classifier performed well at identifying correct etiologies, with F1-Score (harmonic mean of precision-recall) of 0.97. Model precision was 0.99 for adolescent idiopathic scoliosis, 0.89 for congenital, and 0.78 for spinal cord pathology. Performance was higher on more common classes, with lower performance observed in class with fewer images. The algorithm has highest overall precision (0.96), recall (0.96), and F1 (0.96), while Surgeons 1 and 2 have lower accuracies (precision 0.80, recall 0.79, and F1 0.79 and precision 0.76, recall 0.67, and F10.71, respectively). There was no clear pattern identified regarding the surgeons' errors and poor agreement on which X-rays corresponded to underlying spinal cord pathology. Conclusion: A DL-convolutional-neural-network classifier has been trained to high degree of accuracy to distinguish between 3 scoliosis etiologies on pediatric spine radiographs. This model could provide a novel tool to clinicians to decide when to refer for axial imaging. It had superior diagnostic performance compared with experienced spine surgeons. After further validation and refinement, a clinician could put a patient's X-rays into the predictive tool for analysis and use the results to discuss with the family the risk of finding spinal cord pathology, helping them determine together the best timing for an MRI. Level of Evidence: Level III . See Instructions for Authors for a complete description of levels of evidence.
Clinical Reasoning: A 30-Year-Old Female Patient With Multiple Sclerosis Presenting With Rapidly Progressive Cranial Neuropathies, Weakness, and Ataxia
Trentadue, Taylor P. , Sosa, Santiago Martinez , Itoh, Christopher Y. , Modi, Tanish , Triplet, Erin M. , Santilli, Ashley R. , Coon, Elizabeth A. , Toledano, Michel , Trentadue, Taylor P , Martinez Sosa, Santiago , Itoh, Christopher Yuki , Triplet, Erin, Santilli, Ashley R , Coon, Elizabeth Anne , Toledano, Michel , Norgan, Andrew P.

Mayo Clinic

Neurology | November 24, 2025 | Volume: 105 | Issue: 12 | Pages: No page available

10.1212/wnl.0000000000214429 | PMID 41284955 Get It

A systematic review of objective return to sport criteria following hip arthroscopy for athletes
Scott, Parker, Hegarty, Cullen , Johnson, Andrew, Eischen, Joe, Nagelli, Christopher V. , Hevesi, Mario, Hegarty, Cullen J, Nagelli, Christopher, Hegarty, Cullen J., Johnson, Andrew, Eischen, Joe, Krych, Aaron J. , Hevesi, Mario , Johnson, Andrew

Mayo Clinic

Orthopedic Reviews | November 24, 2025 | Volume: 17 | Issue: No issue available | Pages: No page available

10.52965/001c.144729 | PMID 41306379 Get It

Purpose Hip arthroscopy is a minimally invasive procedure which has been increasingly used among athletes for several hip joint related pathologies as it allows for a faster recovery. However, objective return to sport criteria have not been described previously among this population. Objective To systematically review the literature to evaluate and describe the objective return-to-sport (RTS) criteria to release patients back to sport following hip arthroscopy. Methods We conducted a comprehensive literature search according to the PRISMA guidelines. Studies were included in the review if patients underwent a hip arthroscopy procedure and the study described criteria for their patients to RTS. Two independent reviewers selected studies for inclusion and extracted study characteristics and objective RTS criteria. Results Of the 306 that were a part of our original search, 6 studies fit our inclusion criteria. There were 250 athletes (average age: 26.1) and 263 hips which underwent hip arthroscopy surgery. Of these athletes, the cohort was on average 46.5% female and an average of 91.2% of athletes returned to sport about 6 months following surgery. The primary sports these athletes participated in were soccer, swimming, skiing/snowboarding, and hockey. The objective RTS measures that were generally described included sport specific tests, range-of-motion, hip strength, and performance-based criteria. Conclusion There are minimal studies who described objective RTS criteria to release patients back to sport following hip arthroscopy procedures. Sports specific tests, hip strength, and performance-based criteria were mentioned as objective criteria to release patients back to sport.
CHARM is prognostic of geriatric morbidity and toxicity after allogeneic transplant for older adults: BMT CTN 1704 study
Artz, Andrew , Logan, Brent R., Saber, Wael , Geller, Nancy L. , Bellach, Anna , Kou, Jianqun, Wood, William A. , McCarty, John M. , Knight, Thomas G. , Runaas, Lyndsey, Johnston, Laura, Nakamura, Ryotaro , Mishra, Asmita , Uberti, Joseph P., Morris, Lawrence E. , Nadiminti, Kalyan , Olin, Rebecca L. , Sobecks, Ronald , Wall, Sarah , Mattila, Deborah, Protz, Bailey, Horowitz, Mary M. , Artz, Andrew S , Nakamura, Ryotaro , Saultz, Jennifer N , Imus, Philip H , Hogan, William J , Nadiminti, Kalyan V , Bhatt, Vijaya Raj , Devine, Steven , Sorror, Mohamed , Knight, Thomas G , Wood, William A , Walston, Jeremy D , Dahi, Parastoo B , McCurdy, Shannon , Hogan, William J. , Bhatt, Vijaya Raj , Maakaron, Joseph E. , Devine, Steven M. , Sorror, Mohamed L.

Mayo Clinic

Blood Advances | November 21, 2025 | Volume: 10 | Issue: 5 | Pages: 1657-1669

10.1182/bloodadvances.2025018340 | PMID 41269781 Get It

Abstract Despite concerns about the toxicity of allogeneic hematopoietic cell transplantation (alloHCT) in older patients, prospective data characterizing prevalence or risk stratification for geriatric morbidity such as disability or frailty are limited. We prospectively assessed the prognostic impact of the novel composite health assessment risk model (CHARM), a score established to predict 1-year nonrelapse mortality (NRM), among 1105 patients aged ≥60 years enrolled on the Bone Marrow Transplant Clinical Trials Network Study 1704. Secondary end points were assessed post-alloHCT at day 100 (D100), D180, and D365 in multivariable models adjusted with predetermined clinical variables. Among alloHCT survivors, the prevalence of disability by instrumental activities of daily living (IADL), frailty by the Physical Frailty Phenotype, and physical function impairment by Patient Reported Measurement Information System (PROMIS) was highest at D100 and lower on D180 and D365. Higher CHARM scores were independently associated with greater disability (coefficient, −0.64; 95% confidence interval [CI], −0.85 to −0.43; P< .001), increased frailty (coefficient, 0.19; CI, 0.081-0.31; P< .001), worse PROMIS physical function, greater PROMIS depression, increased serious organ toxicity by D100, more cognitive decline at D100, and higher mortality after acute graft-versus-host disease (GVHD) but not significantly associated with PROMIS anxiety or acute GVHD. Higher CHARM scores predicted worse disability-free survival (odds ratio [OR], 2.03; CI, 1.66-2.48; P< .001) and lower frailty-free survival (OR, 2.00; CI, 1.61-2.49). In summary, CHARM is an independent prognostic scoring system not only for NRM but also for geriatric morbidity and functional limitation–free survival through 1 year after alloHCT. Pre-alloHCT CHARM is a novel tool to aid shared decision-making for older patients. This trial was registered at www.clinicaltrials.gov as #NCT03992352.
Trends in Weight Management Among State-Qualifying High School Wrestlers: Implications for Athletes, Clinicians, and Policy Development
Berg, Mark A. , Roberts, William O. , Twohey, Eric , Jagim, Andrew, Jagim, Andrew R.

Mayo Clinic

Journal of Athletic Training | November 21, 2025 | Volume: 61 | Issue: 3 | Pages: 246-250

10.4085/1062-6050-0326.25 | PMID 41816312 Get It

Objective We examined the weight management practices of successful high school wrestlers to contribute meaningful data to the conversations that weight-certifying clinicians and athletic trainers have with athletes at the start of the wrestling season. Understanding how elite athletes navigate weight management can inform safer and more individualized guidance during preseason assessments. Specifically, we sought to determine the proportion of state-qualifying wrestlers who competed at or above their certified minimum weight class. We also quantified the magnitude of weight change from certification to state competition and analyzed seasonal trends in both body weight and body fat percentage over a 20-year period. Design Longitudinal retrospective review. Setting Four Minnesota high schools. Patients or Other Participants State-qualifying wrestlers from 2003 to 2023. Independent Variable State-qualifying weight class. Main Outcome Measure(s) Dependent variables are certification weight, measured body fat percent, and calculated minimum weight class. Results Only 48 wrestlers (52.7%; CI = 42.5%, 63.0%) competed at state in their minimum weight class, while the other 43 competed 1 to 2 weight classes above. Thirty-six wrestlers (39.6%) gained weight over the season. Conclusions Nearly half the successful wrestlers competed in weight classes above their minimum weight, while 5% lost 9% to 18% of their body mass over the wrestling season. This suggests factors other than maximizing individual athletic potential, such as team needs to fill a weight class, influence weight management decisions. Over the 20-year span of the study, trends toward lower measured body fat percentage and lower weight fluctuations suggest influences from sports specialization and year-round training and less emphasis on extreme leanness for competitive advantage. Athletes, in consultation with their coaches and clinicians, should select a competition weight class where they can adequately fuel, train, and recover. This may not be their minimum certified weight class.
MHC class I restricted antigen presentation by Tmem119+ microglia regulates CD8 T cell proliferation in brain parenchyma during neurotropic virus infection 2561
Seady, Marina, Maynes, Mark Andrew, Hassani, Asma, Thelwell, Javonte, Jensen, Hadley E., Owens, Carley A., Hansen, Michael J., Jin, Fang, Johnson, Aaron J., Seady, Marina, Maynes, Mark Andrew, Hassani, Asma, Thelwell, Javonte, Jensen, Hadley E., Owens, Carley A., Hansen, Michael J., Jin, Fang, Johnson, Aaron J.

Mayo Clinic

The Journal of Immunology | November 21, 2025 | Volume: 214 | Issue: Supplement_1 | Pages: No page available

10.1093/jimmun/vkaf283.466 Get It

Abstract Description The importance of microglia class I restricted antigen presentation to brain-infiltrating CD8 T cells has been difficult to define. To address this question, our laboratory generated novel single MHC Class I conditional knockout mice in which H-2Kb or H-2Db can be deactivated specifically in Tmem119+ microglia with tamoxifen administration. Recombinant Theiler’s murine encephalomyelitis virus (TMEV) encoding the model antigen OVA enabled analysis of virus antigen-specific CD8 T cells restricted to Kb class I molecules while Daniel’s strain TMEV Db class I molecules enabled analysis of Db:VP2 specific CD8 T cells. Our results revealed profound differences between MHC class I molecules. Conditional knockout of Kb in Tmem119+ microglia reduced Kb:OVA epitope specific CD8 T cells in the brain compared to Cre negative littermate controls. Employing methodology using FTY720 and BrdU labeling, we determined that deletion of Kb in Tmem119+ microglia reduced proliferation and numbers of Kb:OVA specific CD8 T cells in the brain compared to Cre negative littermate controls. Meanwhile, mice with deletion of Db in Tmem119+ microglia had reduced levels of perforin in Db:VP2 CD8 T cells. These findings demonstrate there are discrete roles for specific MHC Class I molecules on microglia during CNS viral infection. These results plus transgenic mouse systems will help further our understanding of brain infiltrating CD8 T cell responses in neurologic disease. Funding Sources Supported by R01NS122174 and R01NS103212 Topic Categories Neuroimmunology (NEUR)
Conditional ablation of MHC class I antigen presentation on microglia reduces CD8 T cell accumulation in the CNS in a novel tauopathy animal model 9099
Lewis, Cody Lynn, Maynes, Mark Andrew, Thelwell, Javonte , Fryer, John Denis , Johnson, Aaron J. , Lewis, Cody Lynn, Maynes, Mark A , Seady, Marina , Hassani, Asma , Owens, Carley A. , Hansen, Michael J., Jin, Fang , Johnson, Aaron J.

Mayo Clinic

The Journal of Immunology | November 21, 2025 | Volume: 214 | Issue: Supplement_1 | Pages: No page available

10.1093/jimmun/vkaf283.2548 Get It

Abstract Description Tauopathies are a subset of neurological diseases associated with pathologic tau protein accumulation and the formation of neurofibrillary tangles in the brain. There is growing evidence of immune cell infiltration including T cells and an increase of inflammatory microglia in human brains from patients that have Tauopathies. However, the effect of T cells and how they interact with CNS-resident immune cells in these pathologies is not well understood. To answer this question, we developed a neurotropic AAV1 encoding human mutant P301L-Tau. AAV-Tau transduction of neurons in neonatal mice recapitulates features of Tauopathies found in human patients. As microglia are the predominant resident antigen presenting cells within the CNS, we hypothesized that CD8 T cells may be dependent on MHC class I presentation by microglia in mice with Tauopathy to achieve full infiltration and expansion in the brain. To address this hypothesis, we introduced AAV-Tau into our novel transgenic mice for which MHC class I antigen presentation by H-2Kb on microglia can be conditional ablated. We observed lower frequencies of CD8 T cell populations and less CD8 T cell CD69+CD103+ expression in mice with Tauopathy when MHC class I was ablated in microglia. We conclude that microglia class I restricted antigen presentation contributes to the expansion of resident memory CD8 T cells in experimental Tauopathy and therefore are an important driver of the immune response observed in this dementia model. Funding Sources NIH/NINDS: R01NS122174 Mayo Graduate School of Biomedical Sciences Topic Categories Neuroimmunology (NEUR)
Endothelial cell MHC class I molecule restricted antigen presentation to CD8 T cells influences brain infiltration and establishment of antigen experienced T cell populations 3645
Thelwell, Javonte , Maynes, Mark Andrew, Jin, Fang, Johnson, Aaron J. , Maynes, Mark A , Hassani, Asma , Seady, Marina , Hansen, Michael J., Owens, Carley A. , Johnson, Aaron J.

Mayo Clinic

The Journal of Immunology | November 21, 2025 | Volume: 214 | Issue: Supplement_1 | Pages: No page available

10.1093/jimmun/vkaf283.1421 Get It

Abstract Description Brain Barrier (BBB) disruption plays a role in various neurodegenerative diseases such as ALS, stroke, Huntington’s disease and Cerebral Malaria. In our laboratory, we aim to interrogate the immunological underpinnings associated with neuroinflammation and barrier leakage. In clinical studies, aging is associated with a decline in T cell production and a gradual shift to resident memory T cells in the brain characterized by reduced T cell repertoire diversity and weak activation. To model these clinical observations, we sought to define the effect of MHC class I restricted antigen presentation on endothelial cells of brain vasculature on CD8 T cell infiltration of the CNS. We conditionally ablated H-2Kb and H-2Db molecules on endothelial cells using Cdh5-Cre mice crossed with our novel Kb LoxP and Db LoxP mice generated by our research program. In these animals we studied CD8 T cell accumulation in the brain using Theiler’s Murine Endothelial Virus (TMEV) infection of young mice (<12 months) compared to old mice (>12 months). Our results indicate that the loss of endothelial cell Kb induces a defect in establishment of antigen experienced CD8 T cell populations in acute infection. These finding will allow us to further investigate the role of endothelial cell MHC Class I molecules in the immune response to chronic TMEV infection, as well as other neurologic disease models. Funding Sources NIH Grants R01 NS103212 and R01 NS122174 Topic Categories Neuroimmunology (NEUR)